SaCo videolaryngeal mask airway is a novel third generation supraglottic device allowing for continuous observation of entrance to larynx via inserted in special channel videoscope connected with cable with external monitor. In obese patients airway management can be difficult so use of new devices that improve safety and potentially efficacy of airway management is indicated. In prospective observational study the SaCo VLM will be evaluated in terms of maintaining airway patency and effectiveness of intubation through it's lumen in morbidly obese scheduled for elective general surgery under general anesthesia.
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
effectiveness of insertion of SaCo VLM for airway management in morbidly obese
Timeframe: immediate - right after performing insertion of SaCo mask
effectiveness of ventillation using SaCo mask in morbidly obese
Timeframe: immediate - right after insertion of SaCo mask
effectiveness of visualisation of larynx using SaCo VLM in morbidly obese
Timeframe: immediate - right after insertion of SaCo VLM
seal pressure of SaCo VLM in morbidly obese
Timeframe: immediate - right after insertion of SaCo VLM